BMC Public Health (2016) 16:766
DOI 10.1186/s12889-016-3455-5
A Systematic Review and Meta-analysis
Clinical Infectious Diseases® 2016;62(12):1586–94
This new edition and fully updated publication replaces the 2012 UCG and is being circulated free of charge to all public and private sector prescribers, pharmacists, and regulatory authorities in the country
PQDx 0197-045-00 WHO
PQDx PR
March /2016, version 2.0
Guidance for the preparation and submission of dossiers
A survival guide for clinicans.
3rd edition.
Consolidated Guidelines
Geneva, 2016
The End TB Strategy
Journal of Social Aspects of HIV/AIDS VOL. 13 NO. 1 2016
To link to this article: https://doi.org/10.1080/17290376.2016.1226942
HIV/AIDS - Research and Palliative Care 2016:8 183–193
Rueda S, et al. BMJ Open 2016;6:e011453. doi:10.1136/bmjopen-2016-011453
Clinical Infectious Diseases
1586 - 1594 • CID 2016:62 (15 June) • HIV/AIDS
THELANCETID-D-16-00800 S1473-3099(16)30318-8
Sepsis remains a leading cause of mortality and morbidity, especially during the first five days of life and in low and middle-income countries (LMIC) [1]. Hospital infection also remains a major cause of mortality in children despite progress encountered in the last decades.
This Rapid Advice Guideline updates the Interim Guidance on the “Assessment of infants with microcephaly in the context of Zika virus” published in February 2016 (WHO/ZIKV/MOC/16.3). The recommendations provides guidance on the screening, clinical assessment, neuroimaging, laboratory investigati...on and follow-up of children born to women living in areas of Zika virus transmission. The Guideline summarises the evidence base and rationale in support of the recommendations and expands the scope to address complications beyond microcephaly and what is now referred to as the congenital Zika virus syndrome
more